Last reviewed · How we verify

Tetanus Diphtheria Vaccine — Competitive Intelligence Brief

Tetanus Diphtheria Vaccine (Tetanus Diphtheria Vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Toxoid vaccine. Area: Immunology.

marketed Toxoid vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Tetanus Diphtheria Vaccine (Tetanus Diphtheria Vaccine) — Nationwide Children's Hospital. The tetanus-diphtheria vaccine stimulates the immune system to produce antibodies against toxins produced by Clostridium tetani and Corynebacterium diphtheriae bacteria.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tetanus Diphtheria Vaccine TARGET Tetanus Diphtheria Vaccine Nationwide Children's Hospital marketed Toxoid vaccine
Tetanus Toxoid Adsorbed Vaccine Tetanus Toxoid Adsorbed Vaccine Genentech, Inc. marketed Toxoid vaccine Tetanus toxin (tetanospasmin)
tetanus diphtheria toxoids vaccine tetanus diphtheria toxoids vaccine Biogen marketed Toxoid vaccine
Td Td University of Florida marketed Toxoid vaccine Tetanus toxin (tetanospasmin) and diphtheria toxin
Tetanus and Diphtheria Toxoids Adsorbed Tetanus and Diphtheria Toxoids Adsorbed National Institute of Allergy and Infectious Diseases (NIAID) marketed Toxoid vaccine
Td alone Td alone Korea University Guro Hospital marketed Toxoid vaccine Tetanus toxin and diphtheria toxin
Tetanus-diphteria Tetanus-diphteria Hospital Clinic of Barcelona marketed Toxoid vaccine Tetanus toxin (tetanospasmin) and diphtheria toxin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Toxoid vaccine class)

  1. GlaxoSmithKline · 2 drugs in this class
  2. Genentech, Inc. · 1 drug in this class
  3. Hoffmann-La Roche · 1 drug in this class
  4. Hospital Clinic of Barcelona · 1 drug in this class
  5. Korea University Guro Hospital · 1 drug in this class
  6. London School of Hygiene and Tropical Medicine · 1 drug in this class
  7. National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class
  8. Nationwide Children's Hospital · 1 drug in this class
  9. Sanofi Pasteur, a Sanofi Company · 1 drug in this class
  10. Sinovac Life Sciences Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tetanus Diphtheria Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/tetanus-diphtheria-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: